Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Testing the Impact of the MOHR Follow-up Support

University of Colorado, Denver · with National Cancer Institute (NCI) · NCT07569224

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
1000
US sites recruiting
6
Study start
June 2, 2026
Record last updated
June 16, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study will evaluate the impact of 3 different strategies to increase engagement of participants in My Own Health Report (MOHR) and health behavior change activities over time. This study will evaluate the level of engagement, outcomes, cost and cost-effectiveness of these strategies.

Being studied: Providing reminder and resources via messages; Reminder and resources sent via navigation; Regular care

Conditions: Implementation Strategy Bundles for Structured Follow-up

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Adults, aged 18 years and older.
  • Completion of the MOHR health risk assessment and goal-setting tool
  • Score in the "at-risk" range on both of the following cancer risk assessments: 1) Physical activity risk: less than 150 minutes per week of moderate to vigorous physical activity; Diet risk: Less than 5 servings daily of combined fruit/vegetables
  • Patient at one of the participating clinics

Exclusion Criteria

  • Incomplete or no MOHR assessment
  • Language preference/proficiency other than English or Spanish
  • Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation. Examples include - Indices of advanced illness and frailty, such as dementia (ICD-10 codes F01.50, F01.51, F02.80, F02.81, F03.90, F03.91, F10.27, F10.97, G31.09, G31.83 or dementia medication of Donepezil • Galantamine • Rivastigmine, Memantine, or Donepezil-memantine)).

Recruiting US locations

  • University of Colorado Hospital

    Aurora, CO 80045

    Site contact: Rebekah Gomes · 303-724-3115 · rebekah.gomes@cuanschutz.edu

  • UCHealth Women's Integrated Services in Health (WISH)

    Denver, CO 80045

    Site contact: Rebekah Gomes · 303-724-3115 · rebekah.gomes@cuanschutz.edu

  • UCHealth Cherry Creek Medical Center

    Denver, CO 80206

    Site contact: Rebekah Gomes · 303-724-3115 · rebekah.gomes@cuanschutz.edu

  • UCHealth Internal Medical Clinic - Lowry

    Denver, CO 80230

    Site contact: Rebekah Gomes · 303-724-3115 · rebekah.gomes@cuanschutz.edu

  • UCHealth Lone Tree Medical Center

    Lone Tree, CO 80124

    Site contact: Rebekah Gomes · 303-724-3115 · rebekah.gomes@cuanschutz.edu

  • UCHealth Family Medicine - Westminster

    Westminster, CO 80021

    Site contact: Rebekah Gomes · 303-724-3115 · rebekah.gomes@cuanschutz.edu

Study contacts (from the official record)

  • Principal Investigator · (303) 724-2268 · amy.huebschmann@cuanschutz.edu
All healthy volunteers studies in Colorado →
Testing the Impact of the MOHR Follow-up Support (NCT07569224) | Bored Studies